HOME >> MEDICINE >> NEWS
Children with heart defects found to benefit from exercise

moved outdoors when weather permitted.

"One game they particularly enjoyed was 'punch the doctor,'" says Rhodes, referring to a game in which children threw punches at pieces of matting. "A lot of the kids were timid in the beginning, but they were really moving by the end. Being with other kids with heart disease who had never exercised helped melt away a lot of their anxiety. It was quite a metamorphosis."

Heart rate was checked before each session, and 2 to 3 times during the session. For safety, a pulse oximeter and external defibrillator were available on site, but were never needed.

At the end of the program, 15 of 16 children had significantly improved peak work rate, peak oxygen consumption, or both: their hearts were pumping more blood with each beat, and their muscles were using more oxygen. Improvements were as high as 20 percent on some parameters of function. There were no adverse events.

Rhodes's team also conducted follow-up exercise testing 1 year after the pre-program tests (about 7 months after program completion). The results, now under review for publication, showed that participants' cardiac benefits were sustained, whereas non-participating children showed a slight decline in cardiac function. On questionnaires, participants reported exercising more than in the past and had higher behavioral, emotional and self-esteem scores.

Children's plans to launch a formal cardiac rehabilitation program in fall 2006 or spring 2007, when facilities at Children's Hospital Boston at Waltham a new outpatient specialty center in Waltham, Mass. are complete. Rhodes believes that about two-thirds of children with serious congenital heart disease will be eligible to participate. In the pilot study, fewer than 10 percent of children with reduced exercise capacity had conditions that made it dangerous to exercise.

"With the approval of a pediatric cardiologist, and after careful exercise testing, exercise is gener
'"/>

Contact: Bess Andrews
elizabeth.andrews@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
5-Dec-2005


Page: 1 2 3

Related medicine news :

1. Support for Childrens Health and Medicare Protection Act given to House leaders by ACP
2. Children and young people show elevated leukaemia rates near nuclear facilities
3. Childrens brain responses predict impact of sleep loss on attention
4. Children with sleep disorder symptoms are more likely to have trouble academically
5. USC and Childrens Hospital Los Angeles both receive grants for stem cell facilities
6. Children with both autism and ADHD often bully, parents say
7. Childrens Hospital and Pitt lead national trial of hypothermia to treat pediatric brain injury
8. A frown or a smile? Children with autism cant discern
9. Children from low income families more likely to have sleep problems
10. Childrens Hospital Boston presents at the American College of Cardiology Scientific Sessions
11. Children with attention deficit hyperactivity disorder at risk for alcohol problems

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Children with heart defects found benefit from exercise

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: